FQHC Intervention for CGM Uptake in Hispanic Adults with T1D

FQHC 对患有 T1D 的西班牙裔成人 CGM 摄取的干预

基本信息

  • 批准号:
    10709635
  • 负责人:
  • 金额:
    $ 42.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-24 至 2026-07-31
  • 项目状态:
    未结题

项目摘要

Abstract Low-income Hispanic adults with type 1 diabetes (T1D) experience a disproportionate burden of life-threatening, acute complications, both hypoglycemia and diabetes ketoacidosis, with high rates of related emergency department visits, hospitalizations, and death. Use of continuous glucose monitoring (CGM) may mitigate these inequities. Yet, Hispanics with T1D have exceptionally low levels of CGM use. This reflects social determinants of health (SODH), as framed by the multiple levels of the Socio-Ecological Model (SEM). The SEM’s healthcare provider level is a main driver in Hispanic disenfranchisement from CGM. With a severe shortage of endocrinologists, primary care providers are increasingly managing T1D although a high majority report inadequate confidence in titrating insulin and using CGM. With limited access to endocrinology, low-income, Hispanic adults with T1D thus often receive diabetes management in federally qualified health centers (FQHCs) with scant or no access to CGM. Hence, to foster equitable uptake of CGM in the most vulnerable Hispanic adults with T1D, a 4-year, mixed-methods, feasibility study with a pilot randomized controlled trial (RCT) is proposed to primarily assess the feasibility of the SEM-guided intervention (targeting the individual, family/social networks, and healthcare provider levels). The individual level of the intervention fosters essential acquisition of information, motivation, and behavioral skills for CGM uptake through two approaches: (1) 4-week, personalized, CGM sessions with a RN certified in diabetes education; and (2) followed by peer education visits between data collection points. The family/social networks level leverages the core Hispanic values of familismo and collectivismo to promote critical support in CGM uptake with a family member co-attending the 4-week sessions and participant engagement with a peer educator during scheduled visits, respectively. The provider level of the intervention is designed to promote enhanced cultural competency in intervention delivery and provide clinical support for CGM informed by rigorous training in T1D management and CGM via Project ECHO. In study phase 1 (Aim 1), the intervention, informed by stakeholder qualitative findings, will be refined and RCT deployment will be planned with 4 FQHC sites randomized to deliver the intervention (n=2) or control (n=2) conditions with a total enrollment goal of 30 Hispanics with T1D (sites having roughly equivalent enrollment rates). Project ECHO: CGM & T1D Care will also be delivered to intervention site providers. In phase 2 (Aim 2), the feasibility of the study protocol (e.g., recruitment and retention yields, data collection procedures, intervention implementation, and intervention acceptability, among others) will be routinely assessed. In phase 2 (Aim 3), significant intervention signals in terms of physiological (e.g., A1C and time within, above, and below range), psychosocial (e.g., quality of life, family support, physician trust), and behavioral (CGM adherence) outcomes from baseline to 3- and 6- months postbaseline will be assessed. The long-term goal of this study is to inform a large, multi-site RCT, and with successful results, provide a model for CGM uptake in Hispanic adults with T1D for FQHCs nationally
抽象的 患有 1 型糖尿病 (T1D) 的低收入西班牙裔成年人承受着不成比例的危及生命的负担, 急性并发症,包括低血糖和糖尿病酮症酸中毒,相关紧急情况发生率很高 科室就诊、住院和死亡。使用连续血糖监测 (CGM) 可以缓解这些问题 不平等。然而,患有 T1D 的西班牙裔人群 CGM 的使用水平却极低。这反映了社会决定因素 健康(SODH),由社会生态模型(SEM)的多个层面构成。 SEM 的医疗保健 提供者水平是西班牙裔被剥夺 CGM 权利的主要驱动因素。在严重短缺的情况下 内分泌学家、初级保健提供者越来越多地治疗 T1D,尽管大多数报告 对滴定胰岛素和使用 CGM 信心不足。由于获得内分泌学的机会有限,低收入、 因此,患有 T1D 的西班牙裔成年人经常在联邦合格的健康中心 (FQHC) 接受糖尿病治疗 很少或根本无法使用 CGM。因此,为了促进最脆弱的西班牙裔美国人公平地接受 CGM 针对患有 T1D 的成人,一项为期 4 年的混合方法可行性研究,其中包括试点随机对照试验 (RCT) 建议初步评估 SEM 引导干预措施的可行性(针对个人、家庭/社会) 网络和医疗保健提供者级别)。干预的个人水平促进了基本的获得 通过两种方法采用 CGM 的信息、动机和行为技能:(1) 4 周、个性化、 与获得糖尿病教育认证的注册护士进行连续血糖监测 (CGM) 课程; (2) 随后在数据之间进行同伴教育访问 收集点。家庭/社交网络层面利用了西班牙裔家庭主义的核心价值观和 集体主义促进对 CGM 吸收的关键支持,并由家庭成员共同参加为期 4 周的课程 以及参与者在预定访问期间分别与同伴教育者的接触。的提供商级别 干预旨在促进增强干预实施中的文化能力,并提供临床 通过 ECHO 项目对 T1D 管理和 CGM 进行严格培训,为 CGM 提供支持。正在学习阶段 1(目标 1),根据利益相关者的定性调查结果,干预措施将得到完善,RCT 部署将 规划 4 个 FQHC 站点,随机提供干预 (n=2) 或对照 (n=2) 条件,总计 30 名患有 T1D 的西班牙裔美国人的入学目标(入学率大致相当的网站)。 ECHO 项目:CGM & T1D 护理也将提供给干预现场提供者。在第二阶段(目标 2),研究的可行性 协议(例如,招聘和保留率、数据收集程序、干预实施以及 干预的可接受性等)将被定期评估。在第 2 阶段(目标 3),进行重大干预 生理信号(例如 A1C 以及在范围内、高于和低于范围内的时间)、心理社会信号(例如,质量 从基线到 3- 和 6- 的生活、家庭支持、医生信任)和行为(CGM 依从性)结果 将评估基线后几个月。这项研究的长期目标是为大型多中心随机对照试验提供信息,并且 取得成功的结果,为全国 FQHC 的 1 型糖尿病西班牙裔成年人采用 CGM 提供了一个模型

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Veena Channamesetty其他文献

Veena Channamesetty的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Veena Channamesetty', 18)}}的其他基金

FQHC Intervention for CGM Uptake in Hispanic Adults with T1D
FQHC 对患有 T1D 的西班牙裔成人 CGM 摄取的干预
  • 批准号:
    10584250
  • 财政年份:
    2022
  • 资助金额:
    $ 42.99万
  • 项目类别:

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 42.99万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 42.99万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 42.99万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 42.99万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 42.99万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 42.99万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 42.99万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 42.99万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 42.99万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 42.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了